FI963719A - Method for recovering immunoglobulins from fractions from human plasma fractionation - Google Patents

Method for recovering immunoglobulins from fractions from human plasma fractionation Download PDF

Info

Publication number
FI963719A
FI963719A FI963719A FI963719A FI963719A FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A
Authority
FI
Finland
Prior art keywords
fractions
proteins
human plasma
plasma fractionation
prepn
Prior art date
Application number
FI963719A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI963719A0 (en
Inventor
Hanspeter Amstutz
Peter G Lerch
Jean-Jacques Morgenthaler
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of FI963719A0 publication Critical patent/FI963719A0/en
Publication of FI963719A publication Critical patent/FI963719A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

Prodn. of a high-titre immunoglobulin (Ig) prepn. comprises: (a) fractionating blood plasma from a plasma pool to separate ≥ 1 industrially utilisable polyclonal IgG fraction from a residual fraction; (b) preparing a protein soln. from the protein components of the residual fraction or its subfractions; (c) subjecting the protein soln. to ≥ 1 affinity chromatography step in which specific plasma proteins are bound to immobilised ligands of ≥ 1 type and the bound proteins are then released, and (d) converting the released proteins into a high-titre Ig prepn.
FI963719A 1995-09-22 1996-09-19 Method for recovering immunoglobulins from fractions from human plasma fractionation FI963719A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810596A EP0764658B1 (en) 1995-09-22 1995-09-22 Process for obtaining immunoglobulins from fractions originating from the fractionation of human blood plasma

Publications (2)

Publication Number Publication Date
FI963719A0 FI963719A0 (en) 1996-09-19
FI963719A true FI963719A (en) 1997-03-23

Family

ID=8221797

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963719A FI963719A (en) 1995-09-22 1996-09-19 Method for recovering immunoglobulins from fractions from human plasma fractionation

Country Status (21)

Country Link
EP (1) EP0764658B1 (en)
JP (1) JP2952572B2 (en)
KR (1) KR100236762B1 (en)
CN (1) CN1089609C (en)
AT (1) ATE211486T1 (en)
AU (1) AU715427B2 (en)
BR (1) BR9603826A (en)
CA (1) CA2185617A1 (en)
CZ (1) CZ286885B6 (en)
DE (1) DE59509979D1 (en)
DK (1) DK0764658T3 (en)
ES (1) ES2170788T3 (en)
FI (1) FI963719A (en)
HU (1) HUP9602570A3 (en)
MX (1) MX9604256A (en)
NO (1) NO963952L (en)
NZ (1) NZ299394A (en)
PL (1) PL316126A1 (en)
PT (1) PT764658E (en)
RO (1) RO117921B1 (en)
RU (1) RU2157240C2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293119B1 (en) * 1997-06-12 1999-02-11 Mini Ricerca Scient Tecnolog PROCESS FOR THE SEPARATION OF SPECIFIC IMMUNOGLOBULINS FROM STANDARD PLASMA AND THEIR USE FOR THERAPEUTIC TREATMENTS
CN1520885A (en) * 1997-10-23 2004-08-18 ������ҩ��ʽ���� Room temperature storable immunoglobulin preparation for intravenous injection
US8198407B1 (en) * 2004-08-20 2012-06-12 Prometic Biosciences, Ltd. Sequential protein isolation and purification schemes by affinity chromatography
EP2233499A1 (en) 2009-03-26 2010-09-29 CSL Behring AG Antibody composition with altered Fab sialylation
WO2010148117A1 (en) * 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
ITRM20090558A1 (en) * 2009-11-03 2011-05-04 Michele Pitaro PROCEDURE FOR THE PRODUCTION OF IMMUNOGLOBULINES EXTRACTED FROM HUMAN PLASMA FOR THERAPEUTIC USE NEUTRALIZING THE VIRUS OF EPSTEIN BARR AND DRUG CONTAINING DETTE IMMUNOGLOBULINE
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
WO2012012773A1 (en) * 2010-07-23 2012-01-26 Baxter International Inc. Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma
ES2531459B1 (en) * 2013-06-10 2015-12-28 Antonio VILA SANJURJO Method for the physical separation of convoluted "traductomas"
FR3018450B1 (en) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement PROCESS FOR THE PREPARATION OF HUMAN PLASMA PROTEINS
KR20150115639A (en) * 2014-04-04 2015-10-14 전숙영 An acidic buffer solution for manufacturing therapeutic immunoglobulin preparation, manufacturing method of therapeutic immunoglobulin preparation using the acidic buffer solution and therapeutic immunoglobulin preparation maid by this method
GB201413227D0 (en) * 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232004A (en) * 1977-09-21 1980-11-04 American National Red Cross Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith
DE3516119A1 (en) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt POLYVALENT HYPERIMMIMMLOBULIN PREPARATE
IL90281A (en) * 1988-06-06 1994-10-07 Miles Inc Composition consisting of antibodies of the igm type

Also Published As

Publication number Publication date
HUP9602570A2 (en) 1997-08-28
BR9603826A (en) 1998-06-02
CN1153063A (en) 1997-07-02
MX9604256A (en) 1998-04-30
FI963719A0 (en) 1996-09-19
ATE211486T1 (en) 2002-01-15
CN1089609C (en) 2002-08-28
PL316126A1 (en) 1997-04-01
HUP9602570A3 (en) 1998-01-28
EP0764658A1 (en) 1997-03-26
NO963952D0 (en) 1996-09-20
HU9602570D0 (en) 1996-11-28
DE59509979D1 (en) 2002-02-07
EP0764658B1 (en) 2002-01-02
AU6572596A (en) 1997-04-10
ES2170788T3 (en) 2002-08-16
RU2157240C2 (en) 2000-10-10
RO117921B1 (en) 2002-09-30
CZ286885B6 (en) 2000-07-12
CZ274896A3 (en) 1997-04-16
KR100236762B1 (en) 2000-01-15
DK0764658T3 (en) 2002-04-22
NZ299394A (en) 1997-12-19
KR970015745A (en) 1997-04-28
PT764658E (en) 2002-06-28
NO963952L (en) 1997-03-24
JPH09124508A (en) 1997-05-13
AU715427B2 (en) 2000-02-03
CA2185617A1 (en) 1997-03-23
JP2952572B2 (en) 1999-09-27

Similar Documents

Publication Publication Date Title
NO913186D0 (en) PROCEDURE FOR USING AND SYNTHESIS OF PEPTIDES.
KR950700779A (en) Protein purification method
FI963719A (en) Method for recovering immunoglobulins from fractions from human plasma fractionation
ES2106195T3 (en) IGG AGLYCOSILATED ANTIBODY ANTI CD3.
WO2003059935A3 (en) Methods for purifying protein
MX9603637A (en) Antibody purification.
NZ310847A (en) High affinity human monoclonal antibodies specific for rsv fusion protein
CA2006865A1 (en) Humanized immunoglobulins and their production and use
SE9304060D0 (en) Methods to select specific bacteriophages
MX9307316A (en) PROTEINS
DE3484673D1 (en) DIGITALIS ANTIBODIES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE THERAPY OF DIGITALIS INTOXICATIONS.
DE59209129D1 (en) Use of antibody-containing preparations for immunosuppression
DE50011030D1 (en) METHOD FOR THE CHROMATOGRAPHIC FRACTIONATION OF PLASMA OR SERUM, PREPARATIONS THUS OBTAINED AND THEIR USE
FI20095269A (en) Human endothelial cell molecule affecting the binding of lymphocytes
WO1991015582A3 (en) Purified rap gaps, rap gap sequences, and uses thereof
HUP9903789A2 (en) Von willebrand factor derivative and method for isolating proteins
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
HU9203635D0 (en) Method for producing antigene specifical human monoclonal antibodies of high affinity
SE7904276L (en) RENATED CANCER ASSOCIATED PROTEIN
RU95120418A (en) METHOD FOR PRODUCING ALPHA-FETOPROTEIN
ES2148248T3 (en) LIPOPROTEIN PEPTIDES (A) AND THEIR USE.
IT1247534B (en) Antibody NL07 and corresponding production process
WO1998056822A3 (en) Process for the separation of specific immunoglobulins from standard plasma